Cerebral protection devices during transcatheter aortic valve implantation

Trends Cardiovasc Med. 2018 Aug;28(6):412-418. doi: 10.1016/j.tcm.2018.01.007. Epub 2018 Feb 2.

Abstract

Transcatheter aortic valve implantation (TAVI) in patients with aortic valve stenosis is associated with an improvement of clinical outcomes, quality of life, and self-sufficiency. The most feared TAVI-related complication is the occurrence of stroke. In order to reduce peri-procedural cerebral embolizations, diverse cerebral protection devices have been developed. These devices work though deflection or filtering of emboli, and are in different stages of testing. Silent cerebral infarctions identified by diffusion-weighted magnetic resonance imaging (DW-MRI) are used as surrogate primary outcomes, but the clinical significance is still unclear. This review provides a synopsis of the diverse cerebral protection devices and summarizes the current evidence on their efficacy during TAVI.

Keywords: CVA; Cerebral protection device; Cerebrovascular accident; Silent cerebral infarction; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aortic Valve / diagnostic imaging
  • Aortic Valve / physiopathology
  • Aortic Valve / surgery*
  • Aortic Valve Stenosis / diagnostic imaging
  • Aortic Valve Stenosis / physiopathology
  • Aortic Valve Stenosis / surgery*
  • Diffusion Magnetic Resonance Imaging
  • Embolic Protection Devices*
  • Humans
  • Intracranial Embolism / diagnostic imaging
  • Intracranial Embolism / etiology
  • Intracranial Embolism / prevention & control*
  • Prosthesis Design
  • Risk Factors
  • Stroke / diagnostic imaging
  • Stroke / etiology
  • Stroke / prevention & control*
  • Transcatheter Aortic Valve Replacement / adverse effects
  • Transcatheter Aortic Valve Replacement / instrumentation*
  • Treatment Outcome